Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion type Assertion NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_head.
- NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion description "[Furthermore, the overall survival rate of patients with KAI1/CD82-positive adenocarcinoma was also much higher than that of individuals whose adenocarcinoma had reduced KAI1/CD82 expression (73.4% versus 27.1%;P=0.009).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_provenance.
- NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion evidence source_evidence_literature NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_provenance.
- NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion SIO_000772 8620488 NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_provenance.
- NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion wasDerivedFrom befree-20140225 NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_provenance.
- NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_assertion wasGeneratedBy ECO_0000203 NP365579.RADgWMBxDqb4lgbOM9_9px01hjzwtmXFiMgnkDmzG_tFA130_provenance.